stockrowLabcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
- Revenue
- +6.92%
- EPS
- +3.32%
- Free cash flow
- +44.7%
- Total debt
- +3.21%
Quarter to September 2026, against a year earlier
Follow LH
Alert me
Labcorp Holdings Inc. (LH) Shares outstanding
Labcorp Holdings Inc.'s shares outstanding at the end of fiscal 2025 was $83.8M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $81.6M. Over the past ten years it has ranged from $83.8M (fiscal 2025) to $104.3M (fiscal 2016) — the current reading is the lowest in ten years. Labcorp Holdings Inc. ranks 21st of 49 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $83.8M | (0.71%) |
| FY2024 | $84.4M | (3.65%) |
| FY2023 | $87.6M | (4.37%) |
| FY2022 | $91.6M | (6.05%) |
| FY2021 | $97.5M | (0.51%) |
| FY2020 | $98.0M | (0.61%) |
| FY2019 | $98.6M | (3.90%) |
| FY2018 | $102.6M | (1.25%) |
| FY2017 | $103.9M | (0.38%) |
| FY2016 | $104.3M | 3.68% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $81.6M | (0.49%) |
| Jun 2026 | $82.0M | (1.09%) |
| Mar 2026 | $82.9M | (1.07%) |
| Dec 2025 | $83.8M | 0.12% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| A Agilent Technologies, Inc. compare | $283.0M |
| IQV IQVIA Holdings Inc. compare | $167.0M |
| ILMN Illumina, Inc. compare | $154.0M |
| GH Guardant Health, Inc. compare | $134.4M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| WAT Waters Corporation compare | $98.7M |
| LH Labcorp Holdings Inc. | $81.6M |
| MEDP Medpace Holdings, Inc. compare | $28.4M |
| MTD Mettler-Toledo International, Inc. compare | $20.0M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on LH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement